Genetic analysis of the soluble epoxide hydrolase gene, EPHX2, in subclinical cardiovascular disease in the Diabetes Heart Study - Wikidata - awgldk - TriplyDB

Genetic analysis of the soluble epoxide hydrolase gene, EPHX2, in subclinical cardiovascular disease in the Diabetes Heart Study

Genetic analysis of the soluble epoxide hydrolase gene, EPHX2, in subclinical cardiovascular disease in the Diabetes Heart Study

http://www.wikidata.org/entity/Q28395345

about

Soluble epoxide hydrolase: gene structure, expression and deletion Attenuation of cisplatin-induced renal injury by inhibition of soluble epoxide hydrolase involves nuclear factor κB signaling Dysregulation of soluble epoxide hydrolase and lipidomic profiles in anorexia nervosa Variation in the human soluble epoxide hydrolase gene and risk of restenosis after percutaneous coronary intervention Pharmacological inhibition of soluble epoxide hydrolase ameliorates diet-induced metabolic syndrome in rats Adenosine A2A receptor modulates vascular response in soluble epoxide hydrolase-null mice through CYP-epoxygenases and PPARγ Inhibition of soluble epoxide hydrolase preserves cardiomyocytes: role of STAT3 signaling Epoxyeicosanoid signaling in CNS function and disease Disrupting Dimerization Translocates Soluble Epoxide Hydrolase to Peroxisomes Genetics in arterial calcification: pieces of a puzzle and cogs in a wheel.The relationship between race, cigarette smoking and carotid intimal medial thickness in systemic lupus erythematosus.The genetics of vascular complications in diabetes mellitus.The role of epoxide hydrolases in health and disease.Review of the Diabetes Heart Study (DHS) family of studies: a comprehensively examined sample for genetic and epidemiological studies of type 2 diabetes and its complications.Soluble epoxide hydrolase dimerization is required for hydrolase activity.Genome-wide transcriptional analysis of differentially expressed genes in diabetic, healing corneal epithelial cells: hyperglycemia-suppressed TGFβ3 expression contributes to the delay of epithelial wound healing in diabetic corneas.Synergistic Effect of the MTHFR C677T and EPHX2 G860A Polymorphism on the Increased Risk of Ischemic Stroke in Chinese Type 2 Diabetic Patients.Reno-protective mechanisms of epoxyeicosatrienoic acids in cardiovascular disease.Design and discovery of soluble epoxide hydrolase inhibitors for the treatment of cardiovascular diseases.Integrating multi-omics biomarkers and postprandial metabolism to develop personalized treatment for anorexia nervosa.1-(1-acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemia

P2860

Q28291292-FCD8F292-0B23-496E-8108-240B05351DB7 Q28385015-8F059580-4E69-490E-9605-261A840C8D61 Q28390115-D9255ACC-814F-4C68-8694-1A2EFD79F6D0 Q28391736-D59977A8-FC9C-4C23-957A-FE791753F0D7 Q28392609-91614285-CAF1-4B2E-A3F4-51E5DC8B1D4C Q28392991-2D6FAC2A-EA5C-4939-A42C-0EA9FE9C1530 Q28393594-7C613B38-CB96-478B-8895-92F94654352E Q28394441-F27CEFFE-4B88-41C5-9F30-D137F7748319 Q28394802-B8A68F37-2845-4B1E-AC2A-514AE1CB45CC Q33352008-345CF9C4-F97A-4C27-B80C-5919BA3EBECE Q33584053-4C614173-A707-4BD9-9E0C-19E4FB7EA8E6 Q33995879-32C2EC97-04F9-458E-80F1-2BFBEE750C95 Q34440084-A0B9B42B-33C5-4EF5-9093-8FE04029F7A5 Q34703117-80FFBA61-1125-405D-BA65-CBD5D4FDBA97 Q36685182-59732B0B-8232-49FA-B204-831419A0383B Q37510195-49235022-8621-44D1-BE74-00370AE854A7 Q37734321-0EA3FA6D-C322-4CEA-9B6D-3D8C5F23A0FD Q37960812-B7491A52-2C77-47D6-B88D-2E0474427F54 Q38184587-3E1DF845-373D-436A-B313-3603A393D6F8 Q38753914-7DB7287D-79D7-433A-AC94-4284634548D1 Q42100360-134A3B9D-CC7C-40FE-9BFA-F1585DD3014D

P2860

Genetic analysis of the soluble epoxide hydrolase gene, EPHX2, in subclinical cardiovascular disease in the Diabetes Heart Study

http://www.wikidata.org/entity/Q28395345

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Genetic analysis of the solubl ...... se in the Diabetes Heart Study

@ast

Genetic analysis of the solubl ...... se in the Diabetes Heart Study

@en

Genetic analysis of the solubl ...... se in the Diabetes Heart Study

@nl

type

label

Genetic analysis of the solubl ...... se in the Diabetes Heart Study

@ast

Genetic analysis of the solubl ...... se in the Diabetes Heart Study

@en

Genetic analysis of the solubl ...... se in the Diabetes Heart Study

@nl

prefLabel

Genetic analysis of the solubl ...... se in the Diabetes Heart Study

@ast

Genetic analysis of the solubl ...... se in the Diabetes Heart Study

@en

Genetic analysis of the solubl ...... se in the Diabetes Heart Study

@nl

P1433

Q28395345-32C42934-DEAB-4A25-BAA1-2A6C1F3DEDAB

P1476

Q28395345-7E235136-89F7-4261-A412-FE37AC6684D4

P2093

Q28395345-17FECD2B-12E2-451B-B0B4-FD58F4EA52A8

Q28395345-2ADBD379-A1AF-44AF-AFA8-431EDB3137A0

Q28395345-3C7AC3C9-34A5-4847-BFDF-C34A51B775D4

Q28395345-536FA703-D7B2-45EA-AAF9-B042425F018D

Q28395345-661F8AFA-1347-47EA-8C56-6FA7454C1D5E

Q28395345-ECF168E8-2457-4702-BCD4-AB24831CC948

Q28395345-EFCAABEC-473E-4C7B-A1D6-C6502BBF1DF3

P2860

Q28395345-00588D30-6CA1-47B8-AF89-6A53A88A9DF6

Q28395345-0A620918-99F7-43B5-A43F-6FA64E8F0322

Q28395345-1DB40062-38B0-40BA-A2F3-988F1F13F11C

Q28395345-26752C72-1FB7-4FED-AD08-E02F68B711F5

Q28395345-51201D28-0508-4F74-98F3-ABB2708C4EC6

Q28395345-56EA4945-B08F-4AAC-A29E-0DFA1977FA9A

Q28395345-5A5AAE28-5C1A-48F5-90E7-D78EE21B3BC2

Q28395345-6548410F-AA01-4A5D-870A-F089FC46D748

Q28395345-65A1B8C3-58EE-4D28-A92B-374BA55DFAE4

Q28395345-7D3A3D56-E20F-41C0-9CF3-1B049FCE9FAE

P304

Q28395345-D03B91BC-2A9F-4B8B-A78A-426A1FA63144

P31

Q28395345-294986BB-1C6A-41C1-8AC6-5D2D6C8027FA

P3181

Q28395345-3A4C44A3-B3FA-4A74-AF88-D52F4664F81A

P356

Q28395345-3182554B-D330-4422-A5E5-6E0FC5844ADE

P407

Q28395345-EDEA7421-D155-485A-BEFC-DA05499EECE1

P433

Q28395345-75844C68-EF16-40E9-A4BC-9A259F2AE573

P478

Q28395345-E6D7C3C8-1C6E-4968-9820-81207025AC0F

P50

Q28395345-ECD4C315-9634-4CBF-8951-56AF2ED1EC23

P577

Q28395345-9DE26821-9791-454A-96BE-9F9E0FCB8930

P5875

Q28395345-772878DC-EFDB-43EA-8AE9-D723C2E65482

P698

Q28395345-1585B0B6-0726-4256-9C29-E07E872C3573

P921

Q28395345-DAAB664A-8519-4F80-9D0C-BF7200FCF602

P932

Q28395345-C4A3C569-282E-43B6-AB2E-D3F943F6AC55

P3181

P356

P1433

Diabetes and Vascular Disease Research

P1476

Genetic analysis of the solubl ...... se in the Diabetes Heart Study

@en

P2093

Allison B Lehtinen

http://www.w3.org/2001/XMLSchema#string

Barry I Freedman

http://www.w3.org/2001/XMLSchema#string

Carl D Langefeld

http://www.w3.org/2001/XMLSchema#string

David Herrington

http://www.w3.org/2001/XMLSchema#string

Donald W Bowden

http://www.w3.org/2001/XMLSchema#string

J Jeffrey Carr

http://www.w3.org/2001/XMLSchema#string

Stephen S Rich

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study

A second generation human haplotype map of over 3.1 million SNPs

Haploview: analysis and visualization of LD and haplotype maps

Efficiency and power in genetic association studies

Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.

Longitudinal data analysis for discrete and continuous outcomes

Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

Inhibitors of soluble epoxide hydrolase attenuate vascular smooth muscle cell proliferation.

Polymorphism of the soluble epoxide hydrolase is associated with coronary artery calcification in African-American subjects: The Coronary Artery Risk Development in Young Adults (CARDIA) study.

P304

128-34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1481309

http://www.w3.org/2001/XMLSchema#string

P356

10.3132/DVDR.2008.021

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Kathryn P. Burdon

P577

2008-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5320692

http://www.w3.org/2001/XMLSchema#string

P698

18537101

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease

P932

4882928

http://www.w3.org/2001/XMLSchema#string